Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients

Clinical Immunology : the Official Journal of the Clinical Immunology Society
Baruch WolachDirk Roos

Abstract

Chronic granulomatous disease (CGD) is an innate immunodeficiency due to a genetic defect in one of the NADPH-oxidase components. In the course of 21 years, 38 Israeli CGD patients were diagnosed with 17 gene mutations, seven of which were new. Clinical, functional, and molecular studies were accomplished. Although X-linked recessive (XLR)-CGD is worldwide the most common genotype of the disease (~70%), in our study only 11 patients (29%) suffered from XLR-CGD. In Israel, the higher incidence of the autosomal recessive (AR) form of CGD (63%) may be related to consanguineous marriages. In three patients (8%), all four proteins of the NADPH oxidase were present. Severe clinical expression was found both in the XLR and AR forms, but in general a milder disease was evident in AR-CGD, particularly in patients with p47(phox) deficiency. Despite early and aggressive therapy, a mortality rate of 26% was noted. Given that bone-marrow transplantation was successful in five of seven patients, it is recommended to perform it as early as possible before tissue damage is irreversible.

References

Feb 21, 1991·The New England Journal of Medicine·UNKNOWN International Chronic Granulomatous Disease Cooperative Study Group
Sep 1, 1990·The Journal of Infectious Diseases·D M MargolisJ I Gallin
Apr 1, 1989·The Journal of Pediatrics·R MouyC Griscelli
May 2, 1968·The New England Journal of Medicine·R L Baehner, D G Nathan
Nov 1, 1983·Annals of Internal Medicine·J I GallinP Katz
Jan 13, 1995·Journal of Immunological Methods·S J VowellsT A Fleisher
Mar 30, 1994·Biochemical and Biophysical Research Communications·M IwataI Matsuda
Apr 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A WeelR S Weening
Jan 4, 2001·Current Opinion in Hematology·R B Johnston
Feb 13, 2001·Blood Cells, Molecules & Diseases·P G HeyworthA R Cross
Jun 13, 2003·The New England Journal of Medicine·John I GallinSteven M Holland
Sep 1, 2004·Expert Opinion on Biological Therapy·Cecilia N BareseMary C Dinauer
Nov 27, 2007·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Baldassarre MartireUNKNOWN IPINET

❮ Previous
Next ❯

Citations

Jul 27, 2011·Journal of Clinical Immunology·Fatemeh FattahiMostafa Moin
Dec 31, 2011·Journal of Clinical Immunology·Baruch WolachSivan Berger-Achituv
Jun 9, 2009·Clinical Reviews in Allergy & Immunology·Steven M Holland
Dec 1, 1996·Toxicology in Vitro : an International Journal Published in Association with BIBRA·G KempkaG Schlüter
Nov 15, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sophie BlumentalAlain Fischer
Jul 24, 2012·The Journal of Clinical Investigation·Roy MalkaVered Rom-Kedar
May 14, 2010·PloS One·Roy MalkaVered Rom-Kedar
Apr 22, 2010·Journal of Clinical Immunology·Shahram TeimourianDirk Roos
Jun 20, 2014·Journal of Clinical Immunology·Huan XuLi-Ping Jiang
May 24, 2011·Journal of Clinical Immunology·Baruch WolachDirk Roos
Mar 26, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Rebeca Pérez de DiegoAntonio Ferreira
Jan 29, 2013·Hematology/oncology Clinics of North America·Steven M Holland
Aug 30, 2012·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Rebeca Pérez de DiegoAntonio Ferreira Cerdán
Aug 24, 2010·Blood Cells, Molecules & Diseases·Dirk RoosJohn I Gallin
Jul 25, 2009·European Journal of Clinical Investigation·M Y KökerD Roos
Jun 1, 2011·Clinical and Experimental Dermatology·G Isman-NelkenbaumT Zeeli
Mar 23, 2015·Allergologia et immunopathologia·S MeshaalA Elmarsafy
Aug 6, 2013·The Journal of Allergy and Clinical Immunology·Mustafa Yavuz KökerDirk Roos
Jul 6, 2014·The Journal of Allergy and Clinical Immunology·Alessandra MagnaniNizar Mahlaoui
Dec 30, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Beatriz E MarcianoSteven M Holland
Feb 11, 2015·Journal of Clinical Immunology·Yuka OkuraTadashi Ariga
Sep 25, 2017·International Journal of Immunogenetics·M BadalzadehZ Pourpak
Feb 22, 2017·Urologia·Alberto MartiniConstantinos A Constantinides
Sep 28, 2010·Journal of Pediatric Gastroenterology and Nutrition·Anthony L GuerrerioMaria Oliva-Hemker
May 22, 2019·Journal of Clinical Immunology·Jennifer R YonkofUNKNOWN and the United States Immunodeficiency Network Consortium
Apr 10, 2019·Scandinavian Journal of Immunology·Shaghayegh TajikZahra Pourpak
Oct 4, 2012·Expert Review of Anti-infective Therapy·Josef Ben-AriBaruch Wolach
Jul 17, 2015·The Pediatric Infectious Disease Journal·Pietro BortolettoBen Z Katz
Jul 16, 2020·Journal of Clinical Immunology·Idit Lachover RothDavid Hagin
May 26, 2016·Journal of Clinical Immunology·Rabab El HawaryAisha Elmarsafy
May 26, 2016·Journal of Fungi·Jill KingAdilia Warris
May 27, 2020·Indian Journal of Pediatrics·Nameirakpam JohnsonAmit Rawat
Aug 18, 2020·Pediatric Health, Medicine and Therapeutics·Benjamin T PrinceSteven M Holland
Feb 5, 2013·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Carmi Geller-Bernstein, Amos Etzioni
Dec 15, 2016·FEMS Microbiology Reviews·Helene BuvelotKarl-Heinz Krause
Nov 21, 2020·Journal of Clinical Immunology·Dharmagat BhattaraiAmit Rawat
Sep 25, 2020·The Journal of Allergy and Clinical Immunology·Luiza C CamposSiobhan O Burns

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.